Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novartis AG ADR buy skatcup

Start price
21.09.20 / 70%
Target price
Performance (%)
End price
This prediction ended on 05.11.21 with a price of €72.60. With a performance of -3.84%, the BUY prediction by skatcup finished with a loss. Dividends of €2.83 are taken into consideration when calculating the performance. skatcup has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Novartis AG ADR -4.348% -4.348% -7.974%
iShares Core DAX® -5.578% -4.020% 13.017%
iShares Nasdaq 100 -1.758% 3.980% 38.892%
iShares S&P 500 -3.391% 1.204% 34.465%

According to skatcup what are the pros and cons of Novartis AG ADR for the foreseeable future?

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model

Comments by skatcup for this prediction

In the thread Novartis AG ADR diskutieren

Buy Novartis AG ADR

Prediction Buy
Perf. (%) -3.84%
Target price 90.000
Ends at 04.11.21

Kursziel gesetzt auf 90,0

In the thread Trading Novartis AG ADR
Prediction Buy
Perf. (%) -3.84%
Target price 90.000
Ends at 04.11.21

Die von skatcup gewählte maximale Laufzeit wurde überschritten